Limited information is available regarding the epidemiology of uveitis. Worldwide epidemiologic studies may help the clinician in the management of patients with inflammatory ocular diseases, enabling the comparison of different uveitis entities.

Genentech, Bayer, Novartis, and Allergan. He receives research support from Genentech/Roche C. A. Curcio receives research support from Heidelberg Engineering and owns stock of MacRegen. C.G. Besirli is a consultant for iRenix Medical, Janssen, receiveds equity (iRenix Medical) and royalty (iRenix Medical, ONL Therapeutics), clinical trial support (MeiraGTx, Spark Therapeutics, 4DMT, Regeneron, Novartis), and research support

GKR can be considered an alternative to enucleation for the treatment of choroidal melanomas.

Ocular surface squamous neoplasia (OSSN) is the most common non-pigmented malignancy of the ocular surface and is represented in a wide range of histologic diagnoses, ranging from mild epithelial dysplasia to invasive squamous carcinoma. Although surgical excision is still the gold standard for OSSN treatment, interest in conservative medical approaches is steadily growing. We have reviewed all of the literature on OSSN published in English in the MEDLINE database up to May 2018, using the keywords “ocular surface squamous neoplasia,” “squamous conjunctival carcinoma,” and “conjunctival carcinoma in situ,” with the aim to provide a comprehensive review of the most recent evidence on this distinct clinical entity.

Manifestations of herpetic ocular disease in our patients are comparable with other published series. However, the rate of ocular complications and recurrences during follow-up were higher compared with other series.